Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000394008 | SCV000441823 | uncertain significance | Biotinidase deficiency | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002520100 | SCV003655671 | uncertain significance | Inborn genetic diseases | 2022-10-26 | criteria provided, single submitter | clinical testing | The c.196C>A (p.P66T) alteration is located in exon 2 (coding exon 2) of the BTD gene. This alteration results from a C to A substitution at nucleotide position 196, causing the proline (P) at amino acid position 66 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |